188 related articles for article (PubMed ID: 37126315)
21. Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia.
Langslet G; Ose L
Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):1061-6. PubMed ID: 23984929
[TBL] [Abstract][Full Text] [Related]
22. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Lozano P; Henrikson NB; Dunn J; Morrison CC; Nguyen M; Blasi PR; Anderson ML; Whitlock EP
JAMA; 2016 Aug; 316(6):645-55. PubMed ID: 27532919
[TBL] [Abstract][Full Text] [Related]
23. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
Armstrong EP
J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
[TBL] [Abstract][Full Text] [Related]
24. Cascade screening for familial hypercholesterolemia: Practical consequences.
Louter L; Defesche J; Roeters van Lennep J
Atheroscler Suppl; 2017 Nov; 30():77-85. PubMed ID: 29096865
[TBL] [Abstract][Full Text] [Related]
25. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
26. Familial hypercholesterolemia: A systematic review of modeling studies on screening interventions.
Jahn B; Santamaria J; Dieplinger H; Binder CJ; Ebenbichler C; Scholl-Bürgi S; Conrads-Frank A; Rochau U; Kühne F; Stojkov I; Todorovic J; James L; Siebert U
Atherosclerosis; 2022 Aug; 355():15-29. PubMed ID: 35870306
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of Axicabtagene Ciloleucel and Tisagenlecleucel as Second-line or Later Therapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Choe JH; Abdel-Azim H; Padula WV; Abou-El-Enein M
JAMA Netw Open; 2022 Dec; 5(12):e2245956. PubMed ID: 36520440
[TBL] [Abstract][Full Text] [Related]
28. Low-density lipoprotein apheresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
[TBL] [Abstract][Full Text] [Related]
29. Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis.
McKay AJ; Hogan H; Humphries SE; Marks D; Ray KK; Miners A
Atherosclerosis; 2018 Aug; 275():434-443. PubMed ID: 29937236
[TBL] [Abstract][Full Text] [Related]
30. How does cholesterol burden change the case for investing in familial hypercholesterolaemia? A cost-effectiveness analysis.
Faria R; Saramago P; Cox E; Weng S; Iyen B; Akyea RK; Humphries SE; Qureshi N; Woods B
Atherosclerosis; 2023 Feb; 367():40-47. PubMed ID: 36642658
[TBL] [Abstract][Full Text] [Related]
31. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.
Nordestgaard BG; Chapman MJ; Humphries SE; Ginsberg HN; Masana L; Descamps OS; Wiklund O; Hegele RA; Raal FJ; Defesche JC; Wiegman A; Santos RD; Watts GF; Parhofer KG; Hovingh GK; Kovanen PT; Boileau C; Averna M; Borén J; Bruckert E; Catapano AL; Kuivenhoven JA; Pajukanta P; Ray K; Stalenhoef AF; Stroes E; Taskinen MR; Tybjærg-Hansen A;
Eur Heart J; 2013 Dec; 34(45):3478-90a. PubMed ID: 23956253
[TBL] [Abstract][Full Text] [Related]
32. A systematic review of economic evaluations of the detection and treatment of familial hypercholesterolemia.
Ademi Z; Watts GF; Juniper A; Liew D
Int J Cardiol; 2013 Sep; 167(6):2391-6. PubMed ID: 23490080
[TBL] [Abstract][Full Text] [Related]
33. Screening and treatment of familial hypercholesterolemia - Lessons from the past and opportunities for the future (based on the Anitschkow Lecture 2014).
Besseling J; Sjouke B; Kastelein JJ
Atherosclerosis; 2015 Aug; 241(2):597-606. PubMed ID: 26115072
[TBL] [Abstract][Full Text] [Related]
34. Management of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
Robinson JG
J Manag Care Pharm; 2013 Mar; 19(2):139-49. PubMed ID: 23461430
[TBL] [Abstract][Full Text] [Related]
35. Combined population genomic screening for three high-risk conditions in Australia: a modelling study.
Lacaze P; Marquina C; Tiller J; Brotchie A; Kang YJ; Merritt MA; Green RC; Watts GF; Nowak KJ; Manchanda R; Canfell K; James P; Winship I; McNeil JJ; Ademi Z
EClinicalMedicine; 2023 Dec; 66():102297. PubMed ID: 38192593
[TBL] [Abstract][Full Text] [Related]
36. Cascade screening and treatment of children with familial hypercholesterolemia in Turkey.
Kose E; Kose M; Ozturk SI; Ozcan E; Onay H; Ozkan B
J Pediatr Endocrinol Metab; 2020 Aug; 33(10):1251-1256. PubMed ID: 32829317
[TBL] [Abstract][Full Text] [Related]
37. Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated Cholesterol.
Zhang Y; Dron JS; Bellows BK; Khera AV; Liu J; Balte PP; Oelsner EC; Amr SS; Lebo MS; Nagy A; Peloso GM; Natarajan P; Rotter JI; Willer C; Boerwinkle E; Ballantyne CM; Lutsey PL; Fornage M; Lloyd-Jones DM; Hou L; Psaty BM; Bis JC; Floyd JS; Vasan RS; Heard-Costa NL; Carson AP; Hall ME; Rich SS; Guo X; Kazi DS; de Ferranti SD; Moran AE
JAMA Cardiol; 2024 Mar; 9(3):263-271. PubMed ID: 38294787
[TBL] [Abstract][Full Text] [Related]
38. Cost-Effectiveness of Evolocumab Therapy for Myocardial Infarction: The Chinese Healthcare Perspective.
Liang Z; Chen Q; Yang F; Yan X; Zhang X; Chen X; Fang F; Zhao Q
Cardiovasc Drugs Ther; 2021 Aug; 35(4):775-785. PubMed ID: 33090294
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of Financial Incentives for Patients and Physicians to Manage Low-Density Lipoprotein Cholesterol Levels.
Pandya A; Asch DA; Volpp KG; Sy S; Troxel AB; Zhu J; Weinstein MC; Rosenthal MB; Gaziano TA
JAMA Netw Open; 2018 Sep; 1(5):e182008. PubMed ID: 30646152
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
